Advertisement

Autoimmunerkrankungen

  • G. Horneff
  • V. Wahn

Zusammenfassung

Autoimmunität zählt zu den interessantesten Phänomenen, und das Wissen auf diesem Gebiet der Autoimmunerkrankungen hat in den letzten Jahren erhebliche Fortschritte gemacht. Aufgrund der Komplexität der Befunde muss von einer multifaktoriellen Genese ausgegangen werden, bei der neben genetischen Faktoren, zu denen HLA-Moleküle zählen, Hormone, Umwelteinflüsse, Chemikalien und Infektionen von Bedeutung sind. Charakterisiertwerden können Autoimmunerkrankungen oftmals durch humorale oder zelluläre Immunreaktionen gegen körpereigene Gewebe. Zu ihrer Manifestation müssen verschiedene Faktoren zusammentreffen. Systemische Autoimmunerkrankungen sind oft schwer und lebensbedrohlich.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alarcon-Segovia D Villarreal M (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and anti-nuclear natobodies. Excerpta Medica, Amsterdam, pp 33–40Google Scholar
  2. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. (Part II). N Engl J Med 292: 403–407PubMedCrossRefGoogle Scholar
  3. Canadian Hydroxychloroquine Study Group (1991) A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324: 150–154CrossRefGoogle Scholar
  4. Carneiro JR, Sato El (1999) Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.J Rheumatol 26: 1275–1279Google Scholar
  5. Chan TM, Li FK, Tang CS et al. (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343: 1156–1162PubMedCrossRefGoogle Scholar
  6. Dajani AS, Taubert KA, Takahashi M et al. (1994) Guidelines for the long term management of patients with Kawasaki disease. Circulation 89: 916–922PubMedCrossRefGoogle Scholar
  7. Dalakas MC, Lila I, Dambrosia JM et al. (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl 1 Med 329: 1993–2000CrossRefGoogle Scholar
  8. Fu LW, Yang LY,Chen WP, Lin CY (1998) Clinical efficacy of cyclosporin A (Neoral) in the treatment of paediatric lupus nephritis with heavy proteinuria. Br J Rheumatol 37: 217–221Google Scholar
  9. Huber A, Birdi N, McLAine P, Klassen TP, Pothos M (2001) A randomized placebo controlled trial of prednisone in Henoch-Schoenlein purpura. Arthritis Rheum 44 (Suppl): S171Google Scholar
  10. Kato H, Kara T, Inoue 0, Sato N, Akagi T, Sugimura T (1993) Current issues in Kawasaki disease. Acta Paediatr Jpn 35: 464–471PubMedCrossRefGoogle Scholar
  11. Lehman IJA, Sherry DD, Wagner-Weiner L, McCurdy DK, Emery HM, Magilavy DB, Kovalesky A (1988) Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediat 114: 1055–1060CrossRefGoogle Scholar
  12. Medsger IA (1991) Treatment of systemic sclerosis. Ann Rheum Dis 50: 877–886PubMedCrossRefGoogle Scholar
  13. Miller LC, Sisson A, bucker B et al. (1992) Methotrexate treatment of recalcitrant childhood dermatomyositis. Arthritis Rheum 35: 1143–1149PubMedCrossRefGoogle Scholar
  14. Uziel Y, Feldman BM. Krafchik BR, Yeung RS, Laxer RM (2000) Methotrexate and corticosteroid therapy for pediatric localized scleroderma.J Pediatr 136: 91–95Google Scholar
  15. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G et al. (1993) Preliminary criteria for the classification of Sjogren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36: 340–347PubMedCrossRefGoogle Scholar
  16. Wulffraat NM, Sanders LA, Kuis W (2000) Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr Rheumatol Rep 2: 316–323PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • G. Horneff
  • V. Wahn

There are no affiliations available

Personalised recommendations